This report presents the results of the ninth round of the external quality assessment (EQA-9) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
This report presents the results of the fourth round of the EQA on antimicrobial susceptibility testing (AST) for national public health laboratories for Campylobacter (Campylobacter EQA4-AST) within the Food‐ and Waterborne Diseases and Zoonoses Network (FWD-Net). The objectives of this EQA4-AST were to determine the accuracy of quantitative AST results reported by participants; to identify common laboratory problems related to the guidance in the EU protocol, and to assess the overall comparability of routinely collected AST data from national public health reference laboratories across Europe.
This report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019. A total of 952 laboratories (1–95 per country) from 30 EU/EEA countries participated in the EQA exercise.
This is the eighth report for the 2019–20 influenza season. As of week 25/2020, 164 883 influenza detections across the WHO European Region had been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 479 (98%) of 4 568 ascribed to a lineage being B/Victoria.
This is the seventh report for the 2019 2019–20 influenza season. As of week 20 / 16 4 868 influenza detections across the WHO European Region ha have been reported; 73% type A viruses, with A(H1N1)pdm09 prevailing over A(H3N2), and 27% type B viruses, with 4 4 479 (98%) of 4 5 568 ascribed to a lineage being B/Victoria.
This report presents the results of the third round of the external quality assessment (EQA) on antimicrobial
susceptibility testing (AST) for national public health laboratories on Salmonella (hereafter Salmonella EQA3-AST).
The methodology presented in this document provides a way to efficiently estimate COVID-19 prevalence by analysing the results of pooled RT-PCR tests, without the need to identify individual test results. The statistical foundation of the methodology is explained in detail.
ECDC’s influenza virus characterisation reports are published periodically and give an overview of circulating influenza viruses. They provide details on the current vaccine strains, summarise the development of the viruses since the last report, and closely follow the main developments for the ongoing influenza season. Virus characterisation reports are primarily intended for influenza virologists and epidemiologists.